Skip to content

Clinical trials

Obesity trials in France with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Phase: Not applicable Country / region: France Clear all

252 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20054
20062
20075
20089
20093
201013
20119
201210
201313
201415
201514
201614
201714
201816
201916
20206
202114
20228
202316
202412
202520
202615

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed135
Recruiting38
Unknown status33
Terminated23
Not yet recruiting18
Active, not recruiting3
Withdrawn1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital, Clermont-Ferrand31
Assistance Publique - Hôpitaux de Paris26
Hospices Civils de Lyon20
University Hospital, Montpellier15
University Hospital, Toulouse12
Centre Hospitalier Universitaire de Nice10
Nantes University Hospital7
University Hospital, Bordeaux7
University Hospital, Grenoble7
University Hospital, Rouen7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity252
Overweight39
Obesity, Morbid15
Diabetes Mellitus, Type 214
Pediatric Obesity11
Diabetes Mellitus10
Weight Loss10
Metabolic Syndrome9
Insulin Resistance8
Sleep Apnea Syndromes7

Trials

Showing 1 to 25 of 252. Each trial links to its page on Pharma Observatory.

152 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.